Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?
British Journal of Clinical Pharmacology · 30.10.2026
DOI: 10.1002/bcp.70900 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 30.10.2026. Verfasst von Catia Marzolini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Service of Clinical Pharmacology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Service of Clinical Pharmacology, University Hospital Lausanne and University of Lausanne, Lausanne, Switzerland.
- Division of Infectious Diseases, University Hospital Basel and University of Basel, Basel, Switzerland.
- Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.
ORCID-Profile: Catia Marzolini
Zitieren
APA
Marzolini, C., & Khoo, S. (2026). Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70900
Vancouver
Marzolini C, Khoo S. Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70900
BibTeX
@article{Marzolini2026,
author = {Marzolini, Catia and Khoo, Saye},
title = {Dosing HIV integrase inhibitors with enzyme inducers: Convenience vs . control?},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70900}
}
EUVIMED